HIV/AIDS News

Clinical Infectious Diseases has launched a new series that will provide an in-depth look at real-life complex cases and the associated diagnostic and management decisions that ID clinicians deal with regularly.

SAN FRANCISCO — The use of mobile health care units that distribute ART and PrEP medications increased uptake among people who inject drugs, a population at greater risk for acquiring HIV, according to a study.

In HIV, progression of illness or treatment failure is often characterized by increased HIV viral load and decreased CD4+ T-cell count. When illness progression or treatment failure occurs on ART, it is often a result of drug-resistant HIV.

The mass layoffs initiated by HHS this week, including in the upper echelons of the NIH, have sowed chaos and will make Americans less safe from disease, experts warned.

SAN FRANCISCO — Increasing HPV vaccination rates could help decrease the number of cancer cases “attributable to HIV,” according to data from a study presented at the Conference on Retroviruses and Opportunistic Infections.

SAN FRANCISCO — Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, baseline suppressive therapies among adults with HIV.

SAN FRANCISCO — New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly injections already under review by the FDA.

SAN FRANCISCO — Switching to long-acting ART from oral treatments was cost effective for postpartum women with HIV and improved infant outcomes, researchers said at the Conference on Retroviruses and Opportunistic Infections.

SAN FRANCISCO — Researchers here described how they were able to safely and ethically enroll adolescents in a landmark trial of a drug that could transform the landscape of HIV prevention.